By Yuko Tsuchida, Founder and CEO, HITO. October 2026.
North Carolina now relies mainly on discretionary cash grants rather than tax credits. The flagship program, the Job Development Investment Grant (JDIG) (opens in a new tab), returns a percentage of new employees' state income tax withholding for up to 12 years, and the money can be used for any purpose.
JDIG and the One North Carolina Fund are only available for projects where North Carolina is competing with other states, and the application must be made before the company chooses its location. JDIG is currently scheduled to sunset on January 1, 2030.
Life sciences companies have an added resource: the North Carolina Biotechnology Center (opens in a new tab) offers Small Business Research Loans of $150,000 to $350,000 and Strategic Growth Loans of $350,000 to $650,000.
North Carolina's corporate income tax rate is 2% for 2026 and is scheduled to fall to zero by 2030, according to the Department of Revenue (opens in a new tab). With so little income tax, cash grants and loans are the incentives that matter.
Workforce support is a major advantage. NCWorks Customized Training and the state's life sciences training programs help companies recruit and train manufacturing and lab staff.
County tiers affect how much of a JDIG award the company keeps: 100% in Tier 1, 90% in Tier 2, and 75% in Tier 3.
North Carolina has moved away from statutory tax credits toward low tax rates and targeted, negotiated cash incentives. Older programs such as the Article 3J credits and the state R&D credit are no longer available for new activity, so this article focuses only on what companies can use today and through the end of the decade.
For life sciences and biotech companies in 2026, the main tools are the Job Development Investment Grant, the One North Carolina Fund, North Carolina Biotechnology Center loans, the One North Carolina Small Business Fund for federal SBIR and STTR awardees, workforce training through the community college system, and sales tax exemptions for qualifying manufacturing and R&D equipment. Infrastructure and site programs can also support larger projects.
Timing matters most for the grants. JDIG and One NC require that North Carolina be competing with other locations, and the company must apply before it makes its location decision. NCBiotech loans, by contrast, are available on a quarterly cycle to companies already in the state.
North Carolina's corporate income tax is already the lowest among states that levy one, and it is scheduled to disappear. The Department of Revenue's published rates are:
Scroll sideways to see the full table →
| Tax year | Corporate income tax rate |
|---|---|
| 2024 | 2.5% |
| 2025 | 2.25% |
| 2026 | 2.0% |
| 2030 and later | 0%, under the current phase-out schedule |
The individual income tax rate is also falling, to 3.99% for 2026. North Carolina still imposes a franchise tax on corporations at $1.50 per $1,000 of the tax base, with a $500 cap on the first $1 million of base.
This structure changes how incentives work:
For a life sciences company comparing North Carolina with Massachusetts, California, or New Jersey, the combination of low ongoing taxes and upfront cash support is the core of the state's pitch.
The table covers programs available now for life sciences, manufacturing, technology, and service companies. Film, historic rehabilitation, and individual income tax programs are excluded.
Scroll sideways to see the full table →
| Category | Program | Statutory or negotiated | Benefit | Cash? | Apply before you start? |
|---|---|---|---|---|---|
| Job creation | Job Development Investment Grant (opens in a new tab) | Discretionary; awarded by the Economic Investment Committee | Annual grant equal to a percentage of new employees' state income tax withholding, for up to 12 years; company keeps 100%, 90%, or 75% by county tier. Enhanced awards for very large projects | Cash, any use | Yes, before the location decision |
| Deal closing | One North Carolina Fund | Discretionary; requires a local government match | Grant based on jobs, investment, location, and economic impact, paid through the local government | Cash | Yes, before the location decision |
| Life sciences financing | NCBiotech Small Business Research Loan (opens in a new tab) | Competitive | $150,000 to $350,000 for early research and business inception | Loan | Quarterly deadlines |
| Life sciences financing | NCBiotech Strategic Growth Loan (opens in a new tab) | Competitive | $350,000 to $650,000 alongside angel or venture investment for companies past proof of concept | Loan | Quarterly deadlines |
| Federal grant support | One North Carolina Small Business Fund | Competitive | Reimbursement for SBIR/STTR Phase I proposal costs and matching funds for Phase I awardees | Cash | After the federal application or award |
| Training | NCWorks Customized Training | Program-based | Customized training through the North Carolina Community College System for new and expanding companies | In-kind services | Part of project planning |
| Sales tax | Manufacturing and R&D equipment exemptions | Statutory | Exemptions for qualifying manufacturing machinery and for equipment purchased by qualifying R&D companies | Upfront savings | At purchase, with the proper certificate |
| Infrastructure | Utility Account, building reuse, and transportation programs | Discretionary | Grants to local governments for public infrastructure that supports a project | Indirect | Through the local government |
The one-line history. North Carolina's older Article 3J job and investment credits and its R&D tax credit no longer apply to new activity. If you see them described online, they are not part of current planning.
A venture-backed biotech company based in California is choosing between North Carolina and another state for a process development and clinical-scale manufacturing site. All figures are illustrative; JDIG awards are negotiated case by case.
Assumptions:
Scroll sideways to see the full table →
| Incentive | Calculation | Estimated value |
|---|---|---|
| JDIG | $11,400,000 × 4% = $456,000 withholding; × 50% award = $228,000; × 75% company share = $171,000 per year, up to 12 years | Up to about $2,050,000 in cash |
| One North Carolina Fund | Negotiated, with a matching local contribution | Not modeled |
| NCBiotech Strategic Growth Loan | Available if the company meets program criteria | $350,000 to $650,000 loan |
| NCWorks Customized Training | Training for manufacturing and quality staff | In-kind |
| Sales tax exemptions | Qualifying manufacturing and R&D equipment | Depends on equipment mix |
What drives the result:
North Carolina's incentive environment will keep changing over the next few years. For projects planned in that window, four dates and trends matter:
The practical takeaway: companies considering North Carolina in the next two to three years should begin incentive discussions early enough to secure an award before 2030.
The Job Development Investment Grant, a discretionary cash grant equal to a percentage of new employees' state income tax withholding, paid annually for up to 12 years. Companies can use the funds for any purpose.
No state R&D tax credit is available for current activity. Life sciences companies can instead look to NCBiotech loans, the One North Carolina Small Business Fund for SBIR/STTR companies, and sales tax exemptions for qualifying R&D equipment.
Small Business Research Loans range from $150,000 to $350,000, and Strategic Growth Loans range from $350,000 to $650,000, according to NCBiotech's company funding page. Applications are accepted quarterly.
2% for tax year 2026, scheduled to decline to zero by 2030.
Companies in Tier 1 counties keep 100% of each JDIG payment, Tier 2 keeps 90%, and Tier 3 keeps 75%. The rest goes to the state's Utility Account for infrastructure in less prosperous counties.
No. The project must be competitive with locations outside North Carolina, meet wage and health insurance requirements, and be approved before the location decision.
It is scheduled to sunset January 1, 2030. The legislature could extend it, but companies should plan as if awards must be secured before then.
North Carolina's strongest incentives are negotiated grants that disappear once a company commits, plus life sciences financing and training programs that reward planning ahead. With JDIG scheduled to sunset in 2030, the window for many projects is the next few years.
If you are considering North Carolina for a lab, manufacturing site, or headquarters, or advising a client who is, consult with HITO before announcing or signing a lease. We will identify which programs fit your project, estimate their realistic value, and help keep the competitive process in place until awards are secured.
Talk With a HITO Advisor →Related reading: Plan Incentives Before You Pick a Site: A Process Guide for Expansion, Relocation, and Job Creation.
Learn more about our North Carolina tax credits and incentives guide, state specific credits and R&D tax credit services.
Founder and CEO of HITO, an Irvine, California firm that specializes exclusively in tax credits and incentives. HITO works alongside CPAs, CFOs, and business owners to identify, document, and defend federal and state credits and incentives for companies across the U.S.
Verified October 2026.
Disclaimer: this article is for general information and is not tax advice. Incentive programs, funding, and deadlines change, so confirm current terms before you act and consult a qualified advisor about your specific situation.